These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 38036453)
1. Mechanisms of infantile epileptic spasms syndrome: What have we learned from animal models? Ng AC; Choudhary A; Barrett KT; Gavrilovici C; Scantlebury MH Epilepsia; 2024 Feb; 65(2):266-280. PubMed ID: 38036453 [TBL] [Abstract][Full Text] [Related]
2. Cortical Parvalbumin-Positive Interneuron Development and Function Are Altered in the APC Conditional Knockout Mouse Model of Infantile and Epileptic Spasms Syndrome. Ryner RF; Derera ID; Armbruster M; Kansara A; Sommer ME; Pirone A; Noubary F; Jacob M; Dulla CG J Neurosci; 2023 Feb; 43(8):1422-1440. PubMed ID: 36717229 [TBL] [Abstract][Full Text] [Related]
3. Genetic Advancements in Infantile Epileptic Spasms Syndrome and Opportunities for Precision Medicine. Snyder HE; Jain P; RamachandranNair R; Jones KC; Whitney R Genes (Basel); 2024 Feb; 15(3):. PubMed ID: 38540325 [TBL] [Abstract][Full Text] [Related]
4. Landscape of genetic infantile epileptic spasms syndrome-A multicenter cohort of 124 children from India. Nagarajan B; Gowda VK; Yoganathan S; Sharawat IK; Srivastava K; Vora N; Badheka R; Danda S; Kalane U; Kaur A; Madaan P; Mehta S; Negi S; Panda PK; Rajadhyaksha S; Saini AG; Saini L; Shah S; Srinivasan VM; Suthar R; Thomas M; Vyas S; Sankhyan N; Sahu JK Epilepsia Open; 2023 Dec; 8(4):1383-1404. PubMed ID: 37583270 [TBL] [Abstract][Full Text] [Related]
6. Epileptic spasms relapse is associated with response latency but not conventional attributes of post-treatment EEG. Deckard E; Sathe R; Tabibzadeh D; Terango A; Groves A; Rajaraman RR; Nariai H; Hussain SA Epilepsia Open; 2024 Jun; 9(3):1034-1041. PubMed ID: 38588009 [TBL] [Abstract][Full Text] [Related]
7. Infantile epileptic spasms syndrome in children with cardiofaciocutanous syndrome: Clinical presentation and associations with genotype. Kenney-Jung DL; Rogers DJ; Kroening SJ; Zatkalik AL; Whitmarsh AE; Roberts AE; Zenker M; Gambardella ML; Contaldo I; Leoni C; Onesimo R; Zampino G; Tartaglia M; Battaglia DI; Pierpont EI Am J Med Genet C Semin Med Genet; 2022 Dec; 190(4):501-509. PubMed ID: 36448195 [TBL] [Abstract][Full Text] [Related]
8. Long-term analysis of adrenocorticotropic hormone monotherapy for infantile epileptic spasms syndrome with periventricular leukomalacia. Matsuura R; Hamano SI; Hirata Y; Takeda R; Takeuchi H; Koichihara R; Kikuchi K; Oka A Seizure; 2023 Jul; 109():40-44. PubMed ID: 37207538 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of vigabatrin in the treatment of infantile epileptic spasms syndrome: A systematic review and meta-analysis. Xu Z; Gong P; Jiao X; Niu Y; Wu Y; Zhang Y; Chang X; Yang Z Epilepsia Open; 2023 Jun; 8(2):268-277. PubMed ID: 36740237 [TBL] [Abstract][Full Text] [Related]
10. Pathogenesis and new candidate treatments for infantile spasms and early life epileptic encephalopathies: A view from preclinical studies. Galanopoulou AS; Moshé SL Neurobiol Dis; 2015 Jul; 79():135-49. PubMed ID: 25968935 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of vigabatrin in patients with tuberous sclerosis complex and infantile epileptic spasm syndrome: a systematic review. Prezioso G; Chiarelli F; Matricardi S Expert Rev Neurother; 2023; 23(7):661-671. PubMed ID: 37243682 [TBL] [Abstract][Full Text] [Related]
12. Prednisolone or tetracosactide depot for infantile epileptic spasms syndrome? A prospective analysis of data embedded within two randomised controlled trials. Osborne JP; Edwards SW; Alber FD; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick A; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; O'Callaghan FK Eur J Paediatr Neurol; 2023 Jan; 42():110-116. PubMed ID: 36621063 [TBL] [Abstract][Full Text] [Related]
14. Biochemical mechanisms in pathogenesis of infantile epileptic spasm syndrome. Riikonen R Seizure; 2023 Feb; 105():1-9. PubMed ID: 36634586 [TBL] [Abstract][Full Text] [Related]
15. Fifteen years of real-world data on the use of vigabatrin in individuals with infantile epileptic spasms syndrome. Kuchenbuch M; Lo Barco T; Chemaly N; Chiron C; Nabbout R Epilepsia; 2024 Feb; 65(2):430-444. PubMed ID: 37872396 [TBL] [Abstract][Full Text] [Related]
16. Timing the clinical onset of epileptic spasms in infantile epileptic spasms syndrome: A tertiary health center's experience. Hadjinicolaou A; Briscoe Abath C; Singh A; Donatelli S; Salussolia CL; Cohen AL; He J; Gupta N; Merchant S; Zhang B; Olson H; Yuskaitis CJ; Libenson MH; Harini C Epilepsia; 2024 Apr; 65(4):984-994. PubMed ID: 38317356 [TBL] [Abstract][Full Text] [Related]
17. Cohort study of infantile epileptic spasms syndrome: etiological analysis and treatment of corticosteroids. Jiang Y; Zou N; Luo Y; Cheng M; Liao S; Hong S; Liang X; Zhong M; Li T; Jiang L Seizure; 2022 Oct; 101():120-126. PubMed ID: 35952490 [TBL] [Abstract][Full Text] [Related]
18. Early transient dysautonomia predicts the risk of infantile epileptic spasm syndrome onset: A prospective cohort study. Goswami I; Maguire B; Chau V; Tam EW; Pinchefsky E; Whitney R; Wilson D; Miller SP; Cortez MA Front Neurol; 2022; 13():1090155. PubMed ID: 36619920 [TBL] [Abstract][Full Text] [Related]
19. Basic mechanisms of catastrophic epilepsy -- overview from animal models. Galanopoulou AS Brain Dev; 2013 Sep; 35(8):748-56. PubMed ID: 23312951 [TBL] [Abstract][Full Text] [Related]
20. Treatment modalities for infantile spasms: current considerations and evolving strategies in clinical practice. Hollenshead PP; Jackson CN; Cross JV; Witten TE; Anwar AI; Ahmadzadeh S; Shekoohi S; Kaye AD Neurol Sci; 2024 Feb; 45(2):507-514. PubMed ID: 37736852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]